论文信息 - Intermittent (IAD) versus continuous androgen deprivation (CAD) in hormone sensitive metastatic prostate cancer (HSM1PC) patients (pts): Results of S9346 (INT-0162), an international phase III trial. - 字舞流文

Intermittent (IAD) versus continuous androgen deprivation (CAD) in hormone sensitive metastatic prostate cancer (HSM1PC) patients (pts): Results of S9346 (INT-0162), an international phase III trial.

P. Schellhammer | I. Thompson | C. Tangen | E. Crawford | B. Donnelly | C. Higano | E. Small | G. Wilding | E. Crawford | D. Quinn | N. Vogelzang | S. Prescott | U. Vaishampayan | N. Dawson | M. Hussain | D. Raghavan | A. Akdaş | Glenn Liu | P. Venner